Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

REACH RESOURCES LIMITED Capital/Financing Update 2021

Jan 17, 2021

65731_rns_2021-01-17_e684b961-2be9-4f99-a1d6-8b6441fec2aa.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Announcement Summary

Entity name CERVANTES CORPORATION LIMITED

Announcement Type

New announcement

Date of this announcement

Friday January 15, 2021

The Proposed issue is:

A non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)

Total number of +securities proposed to be issued for a non pro rata offer of securities under a disclosure document or product disclosure statement (PDS)

ASX +security code +Security description Maximum Number of+securities to be issued
CVS ORDINARY FULLY PAID 1,000

Closing date for receipt of acceptances Monday April 12, 2021

Proposed +issue date

Tuesday April 13, 2021

Refer to next page for full details of the announcement

Part 1 - Entity and announcement details

1.1 Name of +Entity

CERVANTES CORPORATION LIMITED

We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules.

1.2 Registered Number Type

ABN

Registration Number

79097982235

1.3 ASX issuer code

CVS

1.4 The announcement is

New announcement

1.5 Date of this announcement

Friday January 15, 2021

1.6 The Proposed issue is:

A non-+pro rata offer of +securities under a +disclosure document or +PDS

Part 5 - Details of proposed non-pro rata offer under a disclosure document or PDS

Part 5A - Conditions

5A.1 - Are any of the following approvals required for the non-+pro rata offer of +securities under a +disclosure document or +PDS?

  • +Security holder approval
  • Court approval
  • Lodgement of court order with +ASIC
  • ACCC approval
  • FIRB approval
  • Another approval/condition external to the entity

No

Part 5B - Offer details

Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Existing class

Will the proposed issue of this +security include an offer of attaching +securities? No

Details of +securities proposed to be issued

ASX +security code and description

CVS : ORDINARY FULLY PAID

The number of +securities to be offered under the +disclosure document or +PDS

1,000

Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? No

Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)? No

Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)? No

Offer price details

Has the offer price been determined? Yes

In what currency will the offer be made? What is the offer price per +security? AUD 0.00800

AUD - Australian Dollar

Oversubscription & Scale back details

Will the entity be entitled to accept over-subscriptions? No

Will a scale back be applied if the offer is over-subscribed? No

Will these +securities rank equally in all respects from their issue date with the existing issued +securities in that class? Yes

Part 5C - Timetable

5C.1 Lodgement date of +disclosure document or +PDS with ASIC

Friday January 15, 2021

5C.2 Date when +disclosure document or +PDS and acceptance forms will be made available to investors

Monday January 18, 2021

5C.3 Offer open date

Friday March 12, 2021

5C.4 Closing date for receipt of acceptances

Monday April 12, 2021

5C.6 Proposed +issue date

Tuesday April 13, 2021

Part 5D - Listing Rule requirements

5D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? No

5D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? No

5D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No

5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No

Part 5E - Fees and expenses

5E.1 Will there be a lead manager or broker to the proposed offer? No

5E.2 Is the proposed offer to be underwritten? No

5E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? No

5E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer

Part 5F - Further Information

5F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue

The Company is seeking to raise only a nominal amount of $8 under the Cleansing Offer as the purpose of the Cleansing Offer is not to raise capital

5F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? No

5F.2 Please explain the entity's allocation policy for the offer, including whether or not acceptances from existing +security holders will be given priority

The Cleansing Offer will only be extended to specific parties on invitation from the Directors. Applications for Shares under the Cleansing Offer should only be made if you are instructed to do so by the Company.

5F.3 URL on the entity's website where investors can download the +disclosure document or +PDS

www.cervantescorp.com.au

5F.4 Any other information the entity wishes to provide about the proposed offer

The primary purpose of the Cleansing Offer is to remove any trading restrictions that would otherwise attach to Shares that may be issued by the Company without disclosure under Chapter 6D of the Corporations Act prior to the closing date of the Cleansing Offer.